Τόμος 25 (2007) – Τεύχος 1 – Άρθρο 6 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 25 (2007) – Issue 1– Article 6 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Τίτλος – Title

Μελέτη της Επίδρασης Ανοξίας και Υπογλυκαιμίας στην Έκφραση Νευρωνικών Δεικτών σε Αμφιβληστροειδή και Ιππόκαμπο Επίμυος: Ανάπτυξη ex vivo Μοντέλου Ισχαιμίας

Effect of anoxia and hypoglycaemia on the expression of neuronal cell markers in the rat retina and hippo­campus: Development of a rat ex vivo ischemia model

Συγγραφέας – Author

Άννα Βασιλάκη

Εργαστήριο Φαρμακολογίας, Ιατρική Σχολή, Πανεπιστήμιο Θεσσαλίας, Παπακυριαζή 22, 41222, Λάρισα, Ελλάς

Anna Vasilaki

Laboratory of Pharmacology, Faculty of Medi­cine, University of Thessaly, 22 Papakyriazi str., 41222 Larissa, Greece

Παραπομπή – Citation
Βασιλάκη,Α. : Μελέτη της Επίδρασης Ανοξίας και Υπογλυκαιμίας στην Έκφραση Νευρωνικών Δεικτών σε Αμφιβληστροειδή και Ιππόκαμπο Επίμυος: Ανάπτυξη ex vivo Μοντέλου Ισχαιμίας, Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 25: 25-27 (2007)
Vasilaki,A. : Effect of anoxia and hypoglycaemia on the expression of neuronal cell markers in the rat retina and hippo­campus: Development of a rat ex vivo ischemia model, Epitheorese Klin. Farmakol. Farmakokinet. 25: 25-27 (2007)
Ημερομηνία Δημοσιευσης – Publication Date
2007 – 2007
Γλώσσα Πλήρους Κειμένου –
Full Text Language

Ελληνικά – Greek

Παραγγελία – Αγορά –
Order – Buy
Ηλεκτρονική Μορφή: pdf (15 €)
Digital Type: pdf (15 €)
pharmakonpress[at]pharmakonpress[.]gr
Λέξεις κλειδιά – Keywords
Anoxia, hypoglycaemia, neuronal cell markers, rat, ex vivo ischemia model
Λοιποί Όροι – Other Terms

Άρθρο

Article

Περίληψη – Summary

Neuronal ischemia leads to neuronal cells death due to glucose and oxygen deprivation. The goal of this study was the development of a rat ex vivo ischemia model for the deferential identification of anoxic and hypogly­caemic actions of ischemia on neuronal tissues which could subsequently used for the screening of possible neuroprotective agents.

Methods: The protocol used was a slight modification of one previously reported. In brief, the retina and 500μm thick hippocampal sections were preincubated for 30min in artificial cerebrospinal fluid pH 7.3 (ar­tiCSF) previously buffered with 95%Ο2/5%CO2. Tis­sues were subsequently incubated in artiCSF previ­ously buffered with 95%Ο2/5%CO2 (control and hypogly­caema) or 95%N2/5%CO2 (anoxia) in the pres­ence (control and anoxic conditions) or absence of glu­cose (hypoglycaemia: replacement with sucrose). The effect of anoxia and hypoglycaemia on neuronal cell markers’ expression was studied immunohistochemi­cally using antibodies against choline acetyl-trans­ferase (ChAT), γ-amino-butyric acid (GABΑ), neuronal nitric oxide synthase (bNOS) and neurofilament light (NF-L).

Results/Conclusions: In the retina, ex vivo hypoglycae­mic treatment led to the decrease of ChAT and GABA immunoreactivity in amacrine cells. This decrease was more profound under anoxic conditions. bNOS and NF-L retinal expression as well as GABA hippocampal expression did not seem to be affected by either treat­ment. As far as ChAT, GABA and bNOS immunoreactiv­ity are concerned our results were in agreement with previous studies of in vivo pressure-induced and in vitro chemical-induced retinal ischemia as well as transient cerebral ischemia. On the other hand, NF-L expression failed to correlate to the de­crease of NF-L mRNA levels observed after pressure-induced retinal ischemia/reperfusion. Although further studies are necessary for the assessment of the hypogly­caemia/hypoxia effects on the hippocampal neuronal marker expression this study led to the develop­ment of a conven­ient ex vivo retinal model for the screening of possible neuroprotective agents.

Αναφορές – References
1. Benveniste H., et al.: J. Neurochem. 43: 1369-1374 (1984)

2. Beal M.F.: The Neuroscientist 3: 21-27 (1997)

3. Osborne Ν.Ν., et al.: Retinal Eye Res. 23: 91-147 (2004)

4. Izumi Y., et al.: J. Neurosci. Methods 108: 49-55 (2001)

5. Vasilaki A., et al.: Invest. Ophthalmol. Vis. Sci. 42: 1600-1609 (2001)

6. Mastrodimou N., et al.: Naunyn-Schmiedeberg’s Arch. Pharmacol. 37: 44-53 (2005)

7. Dijk F., Kamphius W.: Brain Res. 1026: 205-217 (2004)

8. Dijk F. et al.: Brain Res. 1026: 194-204 (2004)

9. Chidlow G., Osborne N.N.: Brain Res. 963: 298-306 (2003)

10. Bering R., et al.: Exp. Brain Res. 115: 423-429 (1997)

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
Chemical Abstracts

Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ – ANNUAL SUBSCRIPTION
Γλώσσα Πλήρους Κειμένου –
Full Text Language
Ελληνικά – Greek
Παραγγελία – Αγορά –
Order – Buy
pharmakonpress[at]pharmakonpress[.]gr
pharmakonpress[at]pharmakonpress[.]gr

 

Προσθέστε στους σελιδοδείκτες το μόνιμο σύνδεσμο.

Τα σχόλια είναι απενεργοποιημένα.